These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 4003239)

  • 1. Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Wadworth AN; Murdoch D; Brogden RN
    Drugs; 1991 Sep; 42(3):468-510. PubMed ID: 1720383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol for ventricular ectopy: a dose-response study.
    Fenster PE; Reynolds D; Horwitz LD; Morrison D; Goldman S; Thadani U; Lazzara R; Serokman R; Marcus FI
    Clin Pharmacol Ther; 1987 Jan; 41(1):118-23. PubMed ID: 3802701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous atenolol for ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1986 Sep; 58(6):499-502. PubMed ID: 3529912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
    G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study.
    Krittayaphong R; Bhuripanyo K; Punlee K; Kangkagate C; Chaithiraphan S
    Am Heart J; 2002 Dec; 144(6):e10. PubMed ID: 12486439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy.
    Winkle RA
    Circulation; 1978 Jun; 57(6):1116-21. PubMed ID: 639231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of ventricular arrhythmias by atenolol.
    Heng MK; Zimmer I
    Am Heart J; 1985 Jun; 109(6):1273-80. PubMed ID: 4003239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Causes and treatment of ventricular arrhythmias].
    Kappenberger L
    Schweiz Med Wochenschr; 1990 Jun; 120(25):941-5. PubMed ID: 1695020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular arrhythmias in the elderly: prevalence, mechanisms, and therapeutic implications.
    Fleg JL
    Geriatrics; 1988 Dec; 43(12):23-9. PubMed ID: 3056779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous variability of ventricular arrhythmias in follow-up of anti-arrhythmia therapy].
    Schmidt G; Barthel P; Ulm K; Goedel-Meinen L; Baedeker W
    Herz; 1990 Feb; 15(1):11-20. PubMed ID: 1690167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
    Fitton A; Buckley MT
    Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially lethal ventricular arrhythmias: from mundane to esoteric.
    Kerin NZ; Aragon E; Frumin H; Liu H; Rubenfire M
    J Clin Pharmacol; 1989 May; 29(5):424-8. PubMed ID: 2661601
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.